Amplification of MET gene in anti-EGFR resistant colorectal cancer

被引：0
|
作者：
Bond, Theo
机构：
来源：
PHARMACOGENOMICS | 2013年 / 14卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1249 / 1249
页数：1
相关论文
共 50 条
  • [1] Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
    Bardelli, Alberto
    Corso, Simona
    Bertotti, Andrea
    Hobor, Sebastijan
    Valtorta, Emanuele
    Siravegna, Giulia
    Sartore-Bianchi, Andrea
    Scala, Elisa
    Cassingena, Andrea
    Zecchin, Davide
    Apicella, Maria
    Migliardi, Giorgia
    Galimi, Francesco
    Lauricella, Calogero
    Zanon, Carlo
    Perera, Timothy
    Veronese, Silvio
    Corti, Giorgio
    Amatu, Alessio
    Gambacorta, Marcello
    Diaz, Luis A., Jr.
    Sausen, Mark
    Velculescu, Victor E.
    Comoglio, Paolo
    Trusolino, Livio
    Di Nicolantonio, Federica
    Giordano, Silvia
    Siena, Salvatore
    CANCER DISCOVERY, 2013, 3 (06) : 658 - 673
  • [2] FGF9 gene amplification can induce resistance to anti-EGFR therapy in colorectal cancer
    Mizukami, Takuro
    Togashi, Yosuke
    Banno, Eri
    Terashima, Masato
    de Velasco, Marco A.
    Sakai, Kazuko
    Fujita, Yoshihiko
    Tomida, Shuta
    Nakajima, Takako Eguchi
    Boku, Narikazu
    Nishio, Kazuto
    CANCER RESEARCH, 2015, 75
  • [3] Use of HER2 gene amplification to identify patients with metastatic colorectal cancer resistant to anti-EGFR monoclonal antibodies.
    Barbara, Cecilia
    Martin, Vittoria
    Molinari, Francesca
    Landi, Lorenza
    Riva, Alice
    Saletti, Piercarlo
    de Dosso, Sara
    Geva, Ravit
    Tejpar, Sabine
    Fountzilas, George
    Kalogeras, Konstantine T.
    Frattini, Milo
    Cappuzzo, Federico
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [4] HER2 Amplification and Anti-EGFR Sensitivity in Advanced Colorectal Cancer
    Bregni, Giacomo
    Sciallero, Stefania
    Sobrero, Alberto
    JAMA ONCOLOGY, 2019, 5 (05) : 605 - 606
  • [5] Fibroblast growth factor 9 gene amplification can induce resistance to anti-EGFR therapy in colorectal cancer
    Mizukami, T.
    Togashi, Y.
    Banno, E.
    Terashima, M.
    De Velasco, M. A.
    Sakai, K.
    Hayashi, H.
    Fujita, Y.
    Tomida, S.
    Nakajima, T. Eguchi
    Boku, N.
    Ito, A.
    Nakagawa, K.
    Nishio, K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S46 - S46
  • [6] Significance of FGF9 gene in resistance to anti-EGFR therapies targeting colorectal cancer: A subset of colorectal cancer patients with FGF9 upregulation may be resistant to anti-EGFR therapies
    Mizukami, Takuro
    Togashi, Yosuke
    Naruki, Saeko
    Banno, Eri
    Terashima, Masato
    de Velasco, Marco A.
    Sakai, Kazuko
    Yoneshige, Azusa
    Hayashi, Hidetoshi
    Fujita, Yoshihiko
    Tomida, Shuta
    Nakajima, Takako Eguchi
    Fujino, Takashi
    Boku, Narikazu
    Ito, Akihiko
    Nakagawa, Kazuhiko
    Nishio, Kazuto
    MOLECULAR CARCINOGENESIS, 2017, 56 (01) : 106 - 117
  • [7] Optimizing Anti-EGFR Therapy in Colorectal Cancer
    Salazar, Ramon
    Ciardiello, Fortunato
    CLINICAL CANCER RESEARCH, 2015, 21 (24) : 5415 - 5416
  • [8] EGFR gene copy number decreases during anti-EGFR antibody therapy in colorectal cancer
    Birkman, Eva-Maria
    Avoranta, Tuulia
    Algars, Annika
    Korkeila, Eija
    Lintunen, Minnamaija
    Lahtinen, Laura
    Kuopio, Teijo
    Ristamaki, Raija
    Carpen, Olli
    Sundstrom, Jari
    HUMAN PATHOLOGY, 2018, 82 : 163 - 171
  • [9] Colorectal cancer cells are resistant to anti-EGFR monoclonal antibody through adapted autophagy
    Chen, Zhi
    Gao, Shuohui
    Wang, Dayv
    Song, Defeng
    Feng, Ye
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (02): : 1190 - 1196
  • [10] Acetylation is increased in KRAS mutated colorectal cancer cells that are resistant to anti-EGFR therapies
    Roda, D.
    Zaragoza, R.
    Fernandez, E.
    Torres, L.
    Garcia-Trevijano, E. R.
    Cervantes, A.
    FEBS JOURNAL, 2012, 279 : 311 - 312
12345